home / stock / coep / coep quote
Last: | $11.06 |
---|---|
Change Percent: | -0.48% |
Open: | $10.5 |
Close: | $11.06 |
High: | $11.4 |
Low: | $10.5 |
Volume: | 35,193 |
Last Trade Date Time: | 03/14/2025 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$11.06 | $10.5 | $11.06 | $11.4 | $10.5 | 35,193 | 03-14-2025 |
$10.45 | $11.3 | $10.45 | $11.3 | $10.2983 | 21,827 | 03-13-2025 |
$11.1 | $11 | $11.1 | $11.35 | $10.88 | 21,904 | 03-12-2025 |
$11.01 | $11.04 | $11.01 | $11.75 | $10.9 | 55,232 | 03-11-2025 |
$10.9 | $10.0154 | $10.9 | $11 | $10.0154 | 19,312 | 03-10-2025 |
$10.594 | $10.125 | $10.594 | $10.594 | $10 | 19,730 | 03-07-2025 |
$10.25 | $10.56 | $10.25 | $10.95 | $10.25 | 17,646 | 03-06-2025 |
$10.8 | $10.62 | $10.8 | $11 | $10.62 | 11,051 | 03-05-2025 |
$11 | $10.5 | $11 | $11.5 | $10.11 | 40,215 | 03-04-2025 |
$10.56 | $10 | $10.56 | $11.58 | $9.4771 | 86,402 | 03-03-2025 |
$10.75 | $11.3 | $10.75 | $11.3 | $10.45 | 38,334 | 02-28-2025 |
$10.46 | $11.55 | $10.46 | $11.55 | $10.46 | 23,643 | 02-27-2025 |
$11.28 | $9.27 | $11.28 | $11.79 | $9.2015 | 130,765 | 02-26-2025 |
$9.31 | $9.4 | $9.31 | $9.7514 | $9.31 | 46,974 | 02-25-2025 |
$9.89 | $10.55 | $9.89 | $10.8753 | $9.3 | 52,086 | 02-24-2025 |
$10.52 | $10.86 | $10.52 | $11.14 | $9.8152 | 89,416 | 02-21-2025 |
$11.03 | $12.97 | $11.03 | $13 | $9.27 | 151,490 | 02-20-2025 |
$13.2 | $13.2 | $13.2 | $13.5 | $12.25 | 185,306 | 02-19-2025 |
$13.17 | $12.72 | $13.17 | $13.5 | $11.91 | 106,719 | 02-18-2025 |
$12.45 | $12.25 | $12.45 | $12.69 | $11.85 | 38,427 | 02-17-2025 |
News, Short Squeeze, Breakout and More Instantly...
Coeptis Therapeutics Inc Company Name:
COEP Stock Symbol:
NASDAQ Market:
-0.48% G/L:
$11.06 Last:
35,193 Volume:
$10.50 Open:
$11.06 Close:
Coeptis Therapeutics Inc Website:
2025-02-01 18:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Coeptis Therapeutics Announces First Customer Adoptions of its NexGenAI Marketing Platform PR Newswire Coeptis Secures Five New Clients With Total Contract Value of $1.7 Million Dollars With More On The Horizon Signaling AI-Driven Marketing Innovations in Biopharma for Coe...
Coeptis Therapeutics Announces Reverse Stock Split PR Newswire WEXFORD, Pa. , Dec. 27, 2024 /PRNewswire/ -- Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (the "Company" or "Coeptis"), a biopharmaceutical company focused on pioneering cell therapy platforms f...